Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04377854

Prognostic Value of BNP in MCS - a 25 Year Follow up Study

A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy.

Patients will be followed up for 25 years after inclusion.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Durable Mechanical Support Device Heart Diseases Left Ventricular Assist Device Prognosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

All patients referred for advanced HF treatment at the Dept of Cardiology at Rigshospitalet.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
  • Age>18 years

Exclusion criteria

  • No consent

Treatment and study plan

Observation. No intervention per se.

Other

Observation. No intervention (no collection of blood).

Other names: 1) Observation - No intervention

2) Observation and collection and of blood sample

Other

All patients evaluated for adv HF (HTX/LVAD) will be offered to contribute to this database; Blood samples will be collected from all at baseline. Patients receiving LVAD will contribute on a yearly basis (or until withdrawal of consent). For other patients no further blood will be collected unless they receive an LVAD at a later point.

Other names: Blood sample

Primary outcomes

  1. Alive

    Time frame: 25 years from inclusion

  2. Dead

    Time frame: 25 years from inclusion

    Dead after inclusion in study

Study contacts

Contact information is provided by the study sponsor or research team.

Finn Gustafsson, MD, PhD, DMSci

CONTACT

[email protected]

+4535459743

Kiran Mirza, MD

CONTACT

[email protected]

+4535451442

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Official study title

The Prognostic Value of proBNP in Patients Supported With Durable Mechanical Circulatory Assist Devices - a 25 Year Follow up Study.

Important dates

Study start
2020
Primary completion
2045
Study completion
2045
First posted
May 6, 2020
Registry last updated
May 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.